Healthcare data products and analytic services provider SDI, Plymouth Meeting, Pa., announced that it has purchased Verispan, a Yardley, Pa.-based healthcare data and consulting firm. The deal closed July 28, and no terms were disclosed.
According to the announcement, the transaction creates healthcares most comprehensive de-identified longitudinal database serving the pharmaceutical, biotechnology, medical device, medical/surgical, hospital, pharmacy, financial, payer, consumer packaged goods and government healthcare market segments.
SDI President Andrew Kress, who will serve as chief executive officer of the combined company, said both SDI and Verispan will maintain their main offices. The company will have approximately 700 employees with roughly 500 from Verispan and 200 from SDI, Kress said. He added that a decision hasnt been made on whether products and services will continue to be sold under the Verispan name, but the overall branding will be SDI, Kress said.
Over the past two years, Verispan has been involved with IMS Health, Norwalk, Conn., and Wolters Kluwer Health, Conshohocken, Pa., in seeking to block laws that restrict access to patient pharmaceutical data in Maine, Vermont and New Hampshire (Print subscription required).
A lawsuit filed by IMS Health, Verispan and Wolters Kluwer Health challenging Vermonts data restriction law went to trial July 28 in U.S. District Court in Vermont. According to information provided by SDI, the trial is scheduled to last four days and Verispan and the other plaintiffs have already testified. A ruling is expected within 60 to 90 days. -- by Andis Robeznieks